Chapter 7: A case study of patients organizations: between good causes and hidden clients
Restricted access

Chapter 7 (A case study of patients' organizations: between good causes and hidden clients) provides empirical traction to a nascent literature that has called attention to the potential influence of transnational pharmaceutical companies in the surge of right-to-health litigiousness in some Latin American countries. Furthermore, I present a case study of the multifaceted linkages between patients' organizations that provide pro bono litigation support and transnational pharmaceutical companies. The findings of this chapter are the result of an in-depth immersion in the practice of right-to-health litigation. The "thick narrative" of how actual litigants go about their work offers insights into the crisis of right-to-health litigation in Colombia and Brazil.

You are not authenticated to view the full text of this chapter or article.

Access options

Get access to the full article by using one of the access options below.

Other access options

Redeem Token

Institutional Login

Log in with Open Athens, Shibboleth, or your institutional credentials

Login via Institutional Access

Personal login

Log in with your Elgar Online account

Login with you Elgar account